These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9335192)

  • 41. Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients.
    Assouline S; Sylvestre MP; Carriere P; Shustik C; Laneuville P
    Transfusion; 2006 Feb; 46(2):174-9. PubMed ID: 16441591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
    Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
    Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
    Nakasone H; Kanda Y; Ueda T; Matsumoto K; Shimizu N; Minami J; Sakai R; Hagihara M; Yokota A; Oshima K; Tsukada Y; Tachibana T; Nakaseko C; Fujisawa S; Yano S; Fujita H; Takahashi S; Kanamori H; Okamoto S;
    Am J Hematol; 2009 Dec; 84(12):809-14. PubMed ID: 19862826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peripheral blood stem cell collection in pediatric malignancies: comparison between three mobilizing regimens].
    De Pasquale MD; Cacchione A; Foco M; Gozzer M; Libera F; Soscia F; Ragni G; Cappelli C
    Clin Ter; 2003; 154(5):305-9. PubMed ID: 14994920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
    Lefrère F; Zohar S; Ghez D; Delarue R; Audat F; Suarez F; Hermine O; Damaj G; Maillard N; Ribeil JA; Azagury M; Misbahi R; Jondeau K; Cavazzana-Calvo M; Dal Cortivo L; Varet B
    Bone Marrow Transplant; 2006 Apr; 37(8):725-9. PubMed ID: 16518433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of processed blood volume, leukocyte count and concentration of CD34-positive cells in peripheral blood on efficiency of stem cell apheresis].
    Matic GB; Ullrich H; Barlage S; Rothe G; Schmitz G
    Beitr Infusionsther Transfusionsmed; 1997; 34():139-43. PubMed ID: 9417337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection.
    Corso A; Varettoni M; Mangiacavalli S; Zappasodi P; Klersy C; Rusconi C; Colucci E; Lorenzi A; Troletti D; Consensi E; Lazzarino M
    Leuk Res; 2005 Feb; 29(2):159-63. PubMed ID: 15607364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation of non-typhoidal Salmonella from a haematopoietic progenitor cell product.
    Patterson HC; Sturtevant O; Schott D; Alyea EP; Onderdonk AB; Kao GS
    Transfus Med; 2010 Dec; 20(6):424-5. PubMed ID: 20735761
    [No Abstract]   [Full Text] [Related]  

  • 54. [Directed chemotherapy of ovarian cancer].
    Dvorák O; Andrýsek O; Stránská E
    Cesk Gynekol; 1969 Mar; 34(3):123-6. PubMed ID: 5770712
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of the role of chemotherapy following radical surgery for cilioepithelial tumors of the ovaries].
    Nechaeva ID; Kotova DG; Livshits MA
    Vopr Onkol; 1972; 18(2):32-4. PubMed ID: 4622343
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparison of the effects of Cyclophosphamide, Cytembena and Ypenyl in the treatment of inoperable ovarian neoplasms].
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík J
    Cesk Gynekol; 1971 Sep; 36(7):431-3. PubMed ID: 5110665
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative study of results obtained by various methods of cyclophosphamide therapy in advanced cancer of the ovary].
    Krommer K; Csaba I; Keller G
    Orv Hetil; 1976; 117(20):1205-7. PubMed ID: 1272567
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results of in vitro culturing of ovarian neoplasms and testing with cytostatic agents].
    Spitzbart H; Schmidt F
    Zentralbl Gynakol; 1970 Feb; 92(7):201-5. PubMed ID: 5516074
    [No Abstract]   [Full Text] [Related]  

  • 60. [On hematopoietic changesin patients with malignant ovarian tumors during chemotherapy].
    Turbina IL; Mezentseva SK
    Vopr Onkol; 1965; 11(8):38-41. PubMed ID: 4957708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.